menu
    • menu

    Company profile for Cantex Pharmaceuticals

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cantex Pharmaceuticals, Inc. is a clinical stage pharmaceutical company focused on developing novel treatments for cancer and its life-threatening complications. Cantex’s pipeline consists of three product candidates – Azeliragon, Dicopp® and DSTAT. These drugs are in clinical development for cancers for which innovative and more effective treatments are greatly needed. Cantex is planning clinical trials of azeliragon as...
    Cantex Pharmaceuticals, Inc. is a clinical stage pharmaceutical company focused on developing novel treatments for cancer and its life-threatening complications. Cantex’s pipeline consists of three product candidates – Azeliragon, Dicopp® and DSTAT. These drugs are in clinical development for cancers for which innovative and more effective treatments are greatly needed. Cantex is planning clinical trials of azeliragon as a potential treatment of life-threatening complications of cancer.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cantex PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1792 Bell Tower Lane Weston, FL 33326
    Telephone
    Telephone
    (954) 315-3660
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://cantex.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cantex-pharmaceuticals-inc-/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    CANTEX Pharma Receives FDA Orphan Drug Designation for Azeliragon
    CANTEX Pharma Receives FDA Orphan Drug Designation for Azeliragon

    09 Dec 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cantex-pharmaceuticals-receives-fda-orphan-drug-designation-for-azeliragon-for-the-treatment-of-brain-metastasis-from-breast-cancer-302325038.html

    PR NEWSWIRE
    09 Dec 2024
    Share Share
    Cantex Pharma: Four Azeliragon Abstracts At ASCO 2024 Annual Meeting
    Cantex Pharma: Four Azeliragon Abstracts At ASCO 2024 Annual Meeting

    28 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cantex-pharmaceuticals-announces-four-abstracts-to-be-presented-featuring-azeliragon-at-2024-asco-annual-meeting-302155456.html

    PR NEWSWIRE
    28 May 2024
    Share Share
    CANTEX Gets FDA Orphan Drug For Azeliragon In Pancreatic Cancer
    CANTEX Gets FDA Orphan Drug For Azeliragon In Pancreatic Cancer

    20 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cantex-pharmaceuticals-receives-fda-orphan-drug-designation-for-azeliragon-for-the-treatment-of-pancreatic-cancer-302150254.html

    PR NEWSWIRE
    20 May 2024
    Share Share
    CANTEX TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT
    CANTEX TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT

    19 Mar 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cantex-pharmaceuticals-to-present-at-5th-annual-glioblastoma-drug-development-summit-302092381.html

    PR NEWSWIRE
    19 Mar 2024
    Share Share
    Cantex & Michigan Announce Initiation Of Phase 3 Trial To Evaluate Azeliragon
    Cantex & Michigan Announce Initiation Of Phase 3 Trial To Evaluate Azeliragon

    27 Sep 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cantex-and-michigan-medicine-announce-initiation-of-a-randomized-double-blind-placebo-controlled-multicenter-phase-3-pivotal-clinical-trial-to-evaluate-the-safety-and-efficacy-of-azeliragon-in-the-treatment-of-patients-hospita-301939862.html

    PR NEWSWIRE
    27 Sep 2023
    Share Share
    Cantex and Allegheny Health Announce Initiation of a Phase 1/2 of Azeliragon
    Cantex and Allegheny Health Announce Initiation of a Phase 1/2 of Azeliragon

    26 Sep 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cantex-and-allegheny-health-network-announce-initiation-of-a-phase-12-study-of-azeliragon-in-patients-refractory-to-first-line-treatment-of-metastatic-pancreatic-cancer-301936563.html

    PR NEWSWIRE
    26 Sep 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search